Detalhe da pesquisa
1.
The role of B-Cell Lymphoma-3 (BCL-3) in enabling the hallmarks of cancer: implications for the treatment of colorectal carcinogenesis.
Carcinogenesis
; 41(3): 249-256, 2020 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31930327
2.
Impact of weight loss on cancer-related proteins in serum: results from a cluster randomised controlled trial of individuals with type 2 diabetes.
EBioMedicine
; 100: 104977, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290287
3.
Aspirin and the metabolic hallmark of cancer: novel therapeutic opportunities for colorectal cancer.
Explor Target Antitumor Ther
; 4(4): 600-615, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37720350
4.
Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibition.
Cancer Metab
; 11(1): 18, 2023 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37858256
5.
Identifying metabolic features of colorectal cancer liability using Mendelian randomization.
medRxiv
; 2023 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36945480
6.
BCL-3 promotes a cancer stem cell phenotype by enhancing ß-catenin signalling in colorectal tumour cells.
Dis Model Mech
; 12(3)2019 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30792270